Skip to main content

Animations

MJFF Publications

3471 - 3480 of 6310 Results
Title
Year
  • Year
  • 2021
  • 2018
  • 2025
  • 2022
  • 2017
  • 2022
  • 2020
  • 2006
  • 2014
  • 2023
  • Summary Details
    OPEN
    Title: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.1c00453
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Tau protein aggregation is associated with cellular senescence in the brain
    Journal Name: Aging Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/acel.12840
    Citation Count: 489
  • Summary Details
    OPEN
    Title: Local Ionic Conditions Modulate the Aggregation Propensity and Influence the Structural Polymorphism of α-Synuclein
    Journal Name: Journal of the American Chemical Society
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/jacs.4c13473
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Proximity to residential and workplace pesticides application and the risk of progression of Parkinson's diseases in Central California
    Journal Name: Science of The Total Environment
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scitotenv.2022.160851
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30400-3
    Citation Count: 240
  • Summary Details
    OPEN
    Title: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The Future of GDNF in Parkinson's Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2020.593572
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(06)70579-8
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.06.009
    Citation Count: 219
  • Summary Details
    OPEN
    Title: A proteogenomic view of Parkinson’s disease causality and heterogeneity
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00461-9
    Citation Count: 36
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.